U.S. strikes deal with Lilly for potential COVID-19 antibody drug

  • 📰 Reuters
  • ⏱ Reading Time:
  • 17 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 10%
  • Publisher: 97%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

The U.S. government will pay as much as $1.19 billion to Eli Lilly and Co to secure nearly 1 million doses of its experimental COVID-19 antibody treatment, a drug similar to a treatment that U.S. President Donald Trump received.

Eli Lilly logo is shown on one of the company's offices in San Diego, California, U.S., September 17, 2020. REUTERS/Mike Blake/File Photo

The price per dose amounts to $1,250 as per the contract, but the vials purchased by the government will be free to the American public. While vaccines are seen critical to ending the pandemic, governments are increasingly looking at other effective treatments to slow the spread of the virus and kick-start economic activity.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.

Armenian armed forces, grossly violating the humanitarian ceasefire regime, have fired at the Barda city from the Smerch MLRS. StopArmenianTerrorism StopArmenianAggression StopArmenianOccupation PrayForBarda Barda DontBelieveArmenia

Guessing this is gonna be yet another “deal” where the public pays to develop the drug and then it’s sold back us at 10x the cost.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

NIH Halts Study Exploring Treating Covid-19 With Lilly Antibody, RemdesivirFederal health researchers have halted testing a combination of Eli Lilly’s Covid-19 antibody drug and remdesivir in hospitalized Covid-19 patients, after an independent committee found a lack of a benefit. Guess Trump’s fake illness to boost the market scheme is falling apart. US_FDA where is the science on approval? IraSahira remdesivir yg dlm artikel nano cakap potential tinggi tu kan?
Source: WSJ - 🏆 98. / 63 Read more »

Eli Lilly strikes optimistic tone on COVID-19 therapy after trial failureEli Lilly fell short of analysts' expectations for third-quarter profit due to increased costs to develop COVID-19 therapies and lower demand for some its major drugs, including diabetes treatment Trulicity Breaking: SaudiArabia: An amount of SAR 500K /( $133K) is disbursed to the families of the deceased due to the Corona working in the gov or private health sector, whether civilian or military & whether Saudi or non-Saudi. It applies from the date of recording the 1st infection Thank you realDonaldTrump and SenateGOP_ and HouseGOP for all your hard work to make this coming 3rd wave of Covid-19 not only possible but it is going to be setting record highs for Covid numbers in cases,hospitalizations and deaths while taking away our healthcare coverage good luck
Source: Reuters - 🏆 2. / 97 Read more »